Michael Graves, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), bought 1,000 shares at $56.73 ($57K) on 2016-03-15, disclosed to the SEC on 2016-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CALD | SELL | 2012-02-15 | $354K | — | Filing → |
| CALD | SELL | 2011-11-02 | $127K | — | Filing → |